Coronavirus & Atopic Dermatitis Reporting Registry
SECURE-AD
by Annelie Musters, MD | Angela Bosma, MD on
SECURE-AD (Surveillance Epidemiology of Corona Virus (COVID-19) Under Research Exclusion - Atopic Dermatitis) is a secure, online, de-identified international reporting registry for health care providers to report outcomes of COVID-19 in atopic dermatitis (AD) patients. Clinicians worldwide are encouraged to report all cases of COVID-19 in their AD patients, treated with or without systemic imm …

Continue reading "Coronavirus & Atopic Dermatitis Reporting Registry"

Patient Buzz: Are COVID Toes a True Symptom of COVID-19?
COVID Toes
by Allison Sit on
USA TODAY and countless other media outlets have recently covered a dermatological phenomenon called COVID toes. Are COVID toes a true skin manifestation of COVID-19? For an expert opinion, I consulted dermatologist Amy McMichael, MD, professor and chair of the department of dermatology, Wake Forest Baptist Medical Center, Winston-Salem, N.C. What should dermatologists know about COVID toes? …

Continue reading "Patient Buzz: Are COVID Toes a True Symptom of COVID-19?"

COVID-19 News & Resource Center
COVID-19 News & Resources
by NEXT STEPS IN DERM TEAM on
JDD COVID-19 Webinar Series COVID-19: Urgent Medical and Aesthetic Issues for Dermatology Streamed live on April 1st, 2020, and now available to watch on-demand, this webinar panel provides discussion, guidance, and leadership for dermatologists and dermatology practices during the global coronavirus pandemic. Over the course of 2 hours, 7 different thought leaders join the conversation, dis …

Continue reading "COVID-19 News & Resource Center"

Coronavirus & Alopecia Reporting Database
coronavirus alopecia database
by Dmitri Wall, MD on
SECURE-Alopecia is a physician-entered patient registry to record COVID-19 positive alopecia patient outcomes, on or off treatment, with scarring and non-scarring alopecia. Clinicians worldwide are encouraged to report ALL cases of COVID-19 in their alopecia patients treated with antimalarials, JAK inhibitors (given the emergence of baricitinib as a potential trial COVID-19 therapy), and anti-andr …

Continue reading "Coronavirus & Alopecia Reporting Database"

COVID-19: The Resident and Program Director Perspective
THE IMPACT OF COVID-19 ON DERMATOLOGY RESIDENCY
by Aaron Fong, MD on
On April 22nd, 2020, the Journal of Drugs in Dermatology, Derm In-Review, and the George Washington School of Medicine and Health Sciences hosted a live webinar to answer resident concerns during the global coronavirus pandemic. The webinar was moderated by Dr. Adam Friedman, Professor and Interim Chair of Dermatology at GW and Misty Eleryan, MD, Chief Dermatology Resident at GW. Panelists and s …

Continue reading "COVID-19: The Resident and Program Director Perspective"